New Delhi, Sept. 16 -- The medical device industry has backed Maharashtra Food and Drugs Administration (FDA) commissioner Tukaram Mundhe's call for a national overhaul of device pricing rules.

The support from the Association of Indian Medical Device Industry (AiMeD), representing 1,000 member companies, follows a Maharashtra state survey revealing that private hospitals charge patients for surgical consumables at markups as high as 2,841% over their trade procurement price, Mint reported on Tuesday.

Mundhe has written to the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority (NPPA), urging regulators to cap trade margins or bring essential device categories under structured price monitoring. Similar concer...